| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |